Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Dysphagia
Published in: Dysphagia 1/2012

01-03-2012 | Original Research

A Prospective Investigation of Swallowing, Nutrition, and Patient-rated Functional Impact Following Altered Fractionation Radiotherapy with Concomitant Boost for Oropharyngeal Cancer

Authors: Bena Cartmill, Petrea Cornwell, Elizabeth Ward, Wendy Davidson, Sandro Porceddu

Published in: Dysphagia | Issue 1/2012

Login to get access

Abstract

Altered fractionation radiotherapy for head and neck cancer has been associated with improved locoregional control, overall survival, and heightened toxicity compared with conventional treatment. Swallowing, nutrition, and patient-perceived function for altered fractionation radiotherapy with concomitant boost (AFRT-CB) for T1–T3 oropharyngeal squamous cell carcinoma (SCC) have not been previously reported. Fourteen consecutive patients treated with AFRT-CB for oropharyngeal SCC were recruited from November 2006 to August 2009 in a tertiary hospital in Brisbane, Australia. Swallowing, nutrition, and patient-perceived functional impact assessments were conducted pretreatment, at 4–6 weeks post-treatment, and at 6 months post-treatment. Deterioration from pretreatment to 4–6 weeks post-treatment in swallowing, nutrition, and functional impact was evident, likely due to the heightened toxicity associated with AFRT-CB. There was significant improvement at 6 months post-treatment in functional swallowing, nutritional status, patient-perceived swallowing, and overall function, consistent with recovery from acute toxicity. However, weight and patient perception of physical function and side effects remained significantly worse than pretreatment scores. The ongoing deficits related to weight and patient-perceived outcomes at 6 months revealed that this treatment has a long-term impact on function possibly related to the chronic effects of AFRT-CB.
Literature
1.
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16.PubMedCrossRef
2.
Horiot JC, Le Fur R, N’Guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danczak S, Bolla M, Van Glabbeke M, De Pauw M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;25:231–41.PubMedCrossRef
3.
Saunders MI, Dische S, Barrett A, Parmar MKB, Harvey A, Gibson D. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. Br J Cancer. 1996;73:1455–62.PubMedCrossRef
4.
Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, Wendt CD, Brown BW. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 1990;19:1339–45.PubMedCrossRef
5.
Johnson CR, Schmidt-Ullrich RK, Wazer DE. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. Cancer. 1992;69:2749–54.PubMedCrossRef
6.
Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1985;4:1–7.PubMedCrossRef
7.
Mak AC, Morrison WH, Garden AS, Ang KK, Goepfert H, Peters LJ. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys. 1995;33:289–96.PubMedCrossRef
8.
Yu K, Chua M, Vlantis A, Kam MKM, Lee WY, Tsang RKY, Yuen HY, Hui EP, Chan ATC. Swallowing function after altered fractionation radiotherapy for head and neck carcinoma. J Hong Kong Coll Radiol. 2005;8:207–13.
9.
Zouhair A, Azria D, Pasche P, Stupp R, Chevalier J, Betz M, Mirimanoff RO, Ozsahin M. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer. Radiother Oncol. 2004;70:183–8.PubMedCrossRef
10.
Grobbelaar EJ, Owen S, Torrance AD, Wilson JA. Nutritional challenges in head and neck cancer. Clin Otolaryngol. 2004;29:307–13.PubMedCrossRef
11.
Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, Magnuson JS, Spencer SA, Bonner JA. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;73:410–5.PubMedCrossRef
12.
Kotz T, Abraham S, Beitler JJ, Wadler S, Smith RV. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg. 1999;125:410–3.PubMed
13.
Kumar S, Pandey M, Lal P, Rastogi N, Maria Das KJ, Dimri K. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol. 2005;75:186–92.PubMedCrossRef
14.
Smith R, Goldman S, Beitler J, Wadler S. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:831–6.PubMedCrossRef
15.
Smith R, Kotz T, Beitler J, Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg. 2000;126:384–9.PubMed
16.
Vokes E, Kies M, Haraf D, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000;18:1652–61.PubMed
17.
Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol. 2006;79:34–8.PubMedCrossRef
18.
Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol. 2007;25:4096–103.PubMedCrossRef
19.
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.PubMedCrossRef
20.
van den Berg M, Rasmussen-Conrad E, Gwasara G, Krabbe P, Naber A, Merkx M. A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr. 2006;25:765–72.PubMedCrossRef
21.
Pauloski BR, Rademaker AW, Logemann JA, Stein D, Beery Q, Newman L, Hanchett C, Tusant S, MacCracken E. Pretreatment swallowing function in patients with head and neck cancer. Head Neck. 2000;22:474–82.PubMedCrossRef
22.
Stenson KM, MacCracken E, List M, Haraf DJ, Brockstein B, Weichselbaum R, Vokes EE. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg. 2000;126:371–7.PubMed
23.
Frowen JJ, Perry AR. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck. 2006;28:932–44.PubMedCrossRef
24.
Kendall KA, Leonard RJ, McKenzie SW, Jones CU. Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy. Ann Otol Rhinol Laryngol. 2000;109:767–75.PubMed
25.
Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, MacCracken E, Mittal BB, Vokes EE, Haraf DJ. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck. 2007;29:632–7.PubMedCrossRef
26.
27.
Logemann JA. Evaluation of swallowing disorders. In: Logemann JA, editor. Evaluation and treatment of swallowing disorders. 2nd ed. Austin, TX: Pro-Ed; 1998. p. 89–100.
28.
Dietitians Association of Australia and Speech Pathology Association of Australia Limited. Texture-modified foods and thickened fluids as used for individuals with dysphagia: Australian standardised labels and definitions. Nutr Diet. 2007;64:S53–63.CrossRef
29.
Ward EC, Conroy AL. Validity, reliability, and responsivity of the Royal Brisbane Hospital outcome measure for Swallowing. Asia Pac J Speech Lang Hear. 1999;4:109–29.
30.
Lazarus CL. Effects of radiation therapy and voluntary maneuvers on swallow functioning in head and neck cancer patients. Clin Commun Disord. 1993;3:11–20.PubMed
31.
32.
Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11:93–8.PubMedCrossRef
33.
van der Molen L, van Rossum M, Ackerstaff A, Smeele LE, Rasch C, Hilgers FJ. Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients’ views. BMC Ear Nose Throat Disord. 2009;9:10.PubMedCrossRef
34.
Hughes P, Scott P, Kew J, Cheung DM, Leung SF, Ahuja AT, van Hasselt CA. Dysphagia in treated nasopharyngeal cancer. Head Neck. 2000;22:393–7.PubMedCrossRef
35.
Kendall K, Leonard R. Bolus transit and airway protection coordination in older dysphagic patients. Laryngoscope. 2001;111:2017–21.PubMedCrossRef
36.
Ku P, Yuen E, Cheung D, Chan BY, Ahuja A, Leung SF, Tong MC, van Hasselt A. Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: symptomatology and videofluoroscopic findings. Laryngoscope. 2007;117:142–6.PubMedCrossRef
37.
Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L, Newman L, MacCracken E, Santa D, Mittal B. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008;30:148–58.PubMedCrossRef
38.
Nguyen N, Moltz C, Frank C, Vos P, Smith HJ, Karlsson U, Nguyen LM, Rose S, Dutta S, Sallah S. Evolution of chronic dysphagia following treatment for head and neck cancer. Oral Oncol. 2006;42:374–80.PubMedCrossRef
39.
Ottery F. Patient-generated subjective global assessment. In: McCallum P, Polisena C, editors. The clinical guide to oncology nutrition. Chicago: The American Dietetic Association; 2000. p. 11–23.
40.
Bannerman E, Miller MD, Daniels LA, Cobiac L, Giles LC, Whitehead C, Andrews GR, Crotty M. Anthropometric indices predict physical function and mobility in older Australians: the Australian Longitudinal Study of Ageing. Public Health Nutr. 2002;5:655–62.PubMedCrossRef
41.
42.
Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56:779–85.PubMedCrossRef
43.
Isenring E, Bauer J, Capra S. The scored patient-generated subjective global assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr. 2003;57:305–9.PubMedCrossRef
44.
Chen AY, Frankowshi R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson Dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127:870–6.PubMed
45.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.PubMed
46.
List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: a study of utility and validity. Cancer. 1996;77:2294–301.PubMedCrossRef
47.
D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1996;122:482–7.PubMedCrossRef
48.
Colangelo LA, Logemann JA, Rademaker AW. Tumor size and pretreatment speech and swallowing in patients with resectable tumors. Otolaryngol Head Neck Surg. 2000;122:653–61.PubMedCrossRef
49.
Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck. 2002;24:555–65.PubMedCrossRef
50.
Cheng SS, Terrell JE, Bradford CR, Ronis DL, Fowler KE, Prince ME, Teknos TN, Wolf GT, Duffy SA. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:655–61.PubMedCrossRef
51.
Kaanders JH, Van Daal WA, Hoogenraad WJ, Van der Kogel AJ. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. Int J Radiat Oncol Biol Phys. 1992;24:497–503.PubMedCrossRef
52.
Ang KK, Peters LJ. Concomitant boost radiotherapy in the treatment of head and neck cancers. Semin Radiat Oncol. 1992;2:31–3.CrossRef
53.
Delaney GP, Fisher RJ, Smee RI, Hook C, Barton MB. Split-course accelerated therapy in head and neck cancer: an analysis of toxicity. Int J Radiat Oncol Biol Phys. 1995;32:763–8.PubMedCrossRef
54.
Fu KK, Clery M, Ang KK, Byhardt RW, Maor MH, Beitler JJ. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88–09. Int J Radiat Oncol Biol Phys. 1995;32:589–97.PubMedCrossRef
55.
Olmi P, Cellai E, Chiavacci A, Faliai C. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol. 1990;17:199–207.PubMedCrossRef
56.
Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA. Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol Head Neck Surg. 1998;118:616–24.PubMed
57.
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253–62.PubMedCrossRef
58.
Dworkin JP, Hill SL, Stachler RJ, Meleca RJ, Kewson D. Swallowing function outcomes following nonsurgical therapy for advanced-stage laryngeal carcinoma. Dysphagia. 2006;21:66–74.PubMedCrossRef
59.
Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck. 2006;28:64–73.PubMedCrossRef
60.
Chang YC, Chen SY, Lui LT, Wang TG, Wang TC, Hsiao TY, Li YW, Lien IN. Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study. Dysphagia. 2003;18:135–43.PubMedCrossRef
61.
62.
Beaver ME, Matheny KE, Roberts DB, Myers JN. Predictors of weight loss during radiotherapy. Otolaryngol Head Neck Surg. 2001;125:645–8.PubMedCrossRef
63.
Öhrn KE, Sjoden PO, Wahlin YB, Elf M. Oral health and quality of life among patients with head and neck cancer or haematological malignancies. Support Care Cancer. 2001;9:528–38.PubMedCrossRef
64.
Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A, O’Brien PC, Spry NA, Penniment M, Krawitz H, Williamson S, Bear J, Tripcony L. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol. 1999;52:157–64.PubMedCrossRef
65.
Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–31.PubMedCrossRef
66.
Bleier B, Levine M, Mick R, Rubesin SE, Sack SZ, McKinney K, Mirza N. Dysphagia after chemoradiation: analysis by modified barium swallow. Ann Otol Rhinol Laryngol. 2007;116:837–41.PubMed
67.
Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23–8.PubMedCrossRef
68.
Eisele DW, Koch DG, Tarazi AE, Jones B. Aspiration from delayed radiation fibrosis of the neck. Dysphagia. 1991;6:120–2.PubMedCrossRef
69.
Ekberg O, Nylander G. Pharyngeal dysfunction after treatment for pharyngeal cancer with surgery and radiotherapy. Gastrointest Radiol. 1983;8:97–104.PubMedCrossRef
70.
Logemann JA, Smith CH, Pauloski BR, Rademaker AW, Lazarus CL, Colangelo LA, Mittal B, MacCracken E, Gaziano J, Stachowiak L, Newman LA. Effects of xerostomia on perception and performance of swallow function. Head Neck. 2001;23:317–21.PubMedCrossRef
71.
Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Mittal B, Gaziano J, Stachowiak L, MacCracken E, Newman LA. Xerostomia: 12-Month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck. 2003;25:432–7.PubMedCrossRef
72.
Wu C, Hsiao T, Ko J, Hsu M. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 2000;109:320–5.PubMed
73.
Ng K, Leung SF, Johnson PJ, Woo J. Nutritional consequences of radiotherapy in nasopharynx cancer patients. Nutr Cancer. 2004;49:156–61.PubMedCrossRef
74.
Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer. 2001;93:380–3.PubMedCrossRef
75.
Lee H, Havrila C, Bravo V, Shantz K, Diaz K, Larner J, Read P. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer. 2008;16:285–9.PubMedCrossRef
76.
Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care. 1999;8:133–6.CrossRef
77.
Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, Osoba D. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1992;21:1–11.CrossRef
78.
Campbell BH, Spinelli K, Marbella AM, Myers KB, Kuhn JC, Layde PM. Aspiration, weight loss, and quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg. 2004;130:1100–3.PubMedCrossRef
79.
Tschudi D, Stoeckli S, Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope. 2003;113:1949–54.PubMedCrossRef
80.
Barbosa-Silva MC, Barros AJ. Bioelectric impedance and individual characteristics as prognostic factors for post-operative complications. Clin Nutr. 2005;24:830–8.PubMedCrossRef
81.
Seltzer MH, Slocum BA, Cataldi-Betcher EL, Fileti C, Gerson N. Instant nutritional assessment: absolute weight loss and surgical mortality. JPEN J Parenter Enteral Nutr. 1982;6:218–21.PubMedCrossRef
82.
Van Bokhorst-De Van der Schueren M, Langendoen S, Vondeling H, Kuik D, Quak J, Van Leeuwen P. Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trial. Clin Nutr. 2000;19:437–44.CrossRef
83.
van der Schueren M, van Leeuwen P, Sauerwein H. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck. 1997;19:419–25.CrossRef
84.
de Graeff A, de Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110:98–106.PubMedCrossRef
85.
Terrell J, Ronis D, Fowler K, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:401–8.PubMedCrossRef
86.
Weymuller E Jr, Alsarraf R, Yueh B, Deleyiannis F, Coltrera M. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL–R). Arch Otolaryngol Head Neck Surg. 2001;127:489–93.PubMed
Metadata
Title
A Prospective Investigation of Swallowing, Nutrition, and Patient-rated Functional Impact Following Altered Fractionation Radiotherapy with Concomitant Boost for Oropharyngeal Cancer
Authors
Bena Cartmill
Petrea Cornwell
Elizabeth Ward
Wendy Davidson
Sandro Porceddu
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Dysphagia / Issue 1/2012
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-011-9333-5

Other articles of this Issue 1/2012

Dysphagia 1/2012 Go to the issue

Review Article

Dysphagia is a Common and Serious Problem for Adults with Mental Illness: A Systematic Review

Original Article

Endoscopic Findings in Patients Presenting with Dysphagia: Analysis of a National Endoscopy Database

Original Article

The Dysphagia Handicap Index: Development and Validation

Original Article

Changes in Chemosensitivity and Mechanosensitivity in Aging and Parkinson’s Disease

Original Article

Do Cervical Degenerative Diseases Associate with Foreign Body Sensation of the Pharynx?

Comments

Comments on Selected Recent Dysphagia Literature